Inhibition of Estrogen Receptor Signaling as a Strategy for Radiosensitization of ER plus Breast Cancers

被引：0
|
作者：
Michmerhuizen, A. R. [1 ]
Pesch, A. [1 ]
Schwartz, R. [1 ]
Wilder-Romans, K. [1 ]
Liu, M. [1 ]
Harold, A. [1 ]
Azaria, R. [1 ]
Hayes, D. [1 ]
Rae, J. [1 ]
Pierce, L. J. [2 ]
Schmidt, D. R. [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2507
引用
收藏
页码：E253 / E253
页数：1
相关论文
共 50 条
  • [41] Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers
    Jen-Hwey Chiu
    Che-Sheng Wen
    Jir-You Wang
    Chih-Yi Hsu
    Yi-Fang Tsai
    Shih-Chieh Hung
    Ling-Ming Tseng
    Yi-Ming Shyr
    Journal of Translational Medicine, 15
  • [42] Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers
    Chiu, Jen-Hwey
    Wen, Che-Sheng
    Wang, Jir-You
    Hsu, Chih-Yi
    Tsai, Yi-Fang
    Hung, Shih-Chieh
    Tseng, Ling-Ming
    Shyr, Yi-Ming
    JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15
  • [43] Estrogen Receptor (ER) mRNA and ER -Related Gene Expression in Breast Cancers That Are 1%-10% ER -Positive by Immunohistochemistry.
    Iwamoto, T.
    Booser, D.
    Valero, V.
    Murray, J. L.
    Koenig, K.
    Esteva, F. J.
    Ueno, N. T.
    Zhang, J.
    Shi, W.
    Qi, Y.
    Matsuoka, J.
    Hortobagyi, G. N.
    Hatzis, C.
    Symmans, W. F.
    Pusztai, L.
    CANCER RESEARCH, 2011, 71
  • [44] Triple positive (androgen receptor plus , estrogen receptor+ and HER2+) breast cancers
    Orsaria, M.
    Khelifa, S.
    Tavassoli, F.
    VIRCHOWS ARCHIV, 2011, 459 : S78 - S78
  • [45] Inhibiting androgen receptor nuclear localization decreases estrogen receptor (ER) activity and tumor growth in ER plus breast cancer
    D'Amato, Nicholas C.
    Jacobsen, Britta M.
    Cochrane, Dawn R.
    Spoelstra, Nicole S.
    Babbs, Beatrice L.
    Elias, Anthony
    Richer, Jennifer K.
    CANCER RESEARCH, 2015, 75
  • [46] Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers
    Mitsuya Itoh
    Takayuki Iwamoto
    Junji Matsuoka
    Tomohiro Nogami
    Takayuki Motoki
    Tadahiko Shien
    Naruto Taira
    Naoki Niikura
    Naoki Hayashi
    Shoichiro Ohtani
    Kenji Higaki
    Toshiyoshi Fujiwara
    Hiroyoshi Doihara
    W. Fraser Symmans
    Lajos Pusztai
    Breast Cancer Research and Treatment, 2014, 143 : 403 - 409
  • [47] Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers
    Itoh, Mitsuya
    Iwamoto, Takayuki
    Matsuoka, Junji
    Nogami, Tomohiro
    Motoki, Takayuki
    Shien, Tadahiko
    Taira, Naruto
    Niikura, Naoki
    Hayashi, Naoki
    Ohtani, Shoichiro
    Higaki, Kenji
    Fujiwara, Toshiyoshi
    Doihara, Hiroyoshi
    Symmans, W. Fraser
    Pusztai, Lajos
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 143 (02) : 403 - 409
  • [48] Therapeutic implications of estrogen receptor signaling in HER2-positive breast cancers
    Rita Nahta
    Ruth M. O’Regan
    Breast Cancer Research and Treatment, 2012, 135 : 39 - 48
  • [49] Estrogen receptor-α signaling in post-natal mammary development and breast cancers
    Rusidze, Mariam
    Adlanmerini, Marine
    Chantalat, Elodie
    Raymond-Letron, I.
    Cayre, Surya
    Arnal, Jean-Francois
    Deugnier, Marie-Ange
    Lenfant, Francoise
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2021, 78 (15) : 5681 - 5705
  • [50] Molecular features of dormancy in ER plus breast cancers
    Clarke, Robert
    Dixon, Michael J.
    Jin, Lu
    Turnbull, Aaron
    Hu, Rong
    Zwart, Alan
    Wang, Yue
    Xuan, Jianhua
    Sengupta, Surojeet
    Renshaw, Lorna
    Sims, Andrew
    Liu, Minetta C.
    CANCER RESEARCH, 2018, 78 (04)
12345